Skip to main content

Table 3 Baseline demographic data

From: Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD)

 

Venofer 200

Cosmofer 200

Monofer 200

Monfer 1000

Total group

Age, years

49.5 (4.3)

66.2 (2.3)

59.6 (5.0)

58.8 (5.9)

58.3 (4.4)

Male/female, numbers

6/4

6/4

4/6

7/3

23/17

Serum ferritin, μg/L

58.5 (11.6)

80.8 (20.6)

60.5 (9.5)

66.6 (18.4)

66.6 (15.0)

Transferrin saturation percentage

21.1 (2.9)

25.4 (4.9)

21.2 (3.1)

18.1 (1.7)

21.2 (3.2)

Hemoglobin

121.4 (4.8)

129.1 (7.4)

122.5 (5.0)

115.4 (4.7)

121.6 (5.5)

Serum creatinine, micromole/L

278.7 (42.8)

255.8 (39.6)

175.6 (16.8)

258.5 (30.5)

242.2 (51.2)

eGFR, mL/min per 1.73 m2

25.7 (4.8)

26.7 (3.9)

32.9 (3.8)

25.9 (3.6)

27.8 (4.0)

uACR, mg/mmol

45.8 (24.5)

11.2 (5.76)

234.0 (154)

145.6 (77.1)

110.1 (65.3)

uPCR, mg/mmol

236.3 (104.5)

117.5 (68.1)

20 (0.5)

164 (94.6)

104.3 (67)

C-reactive protein, mg/L

8.8 (3.3)

5.6 (1.9)

7.7 (2.9)

4.6 (1.0)

6.7 (2.3)

Albumin, g/L

34.6 (3.7)

37.1 (3.2)

35.2 (3.8)

32.6 (3.5)

34.88 (3.55)

  1. Mean values and the standard error of the mean for each of the four intravenous iron groups (n = 10 per group)
  2. Abbreviations: eGFR estimated glomerular filtration rate, uACR/uPCR urinary albumin:creatinine ratio/urinary protein:creatinine ratio